September 11, 2018 | Dory Benford
Johnny Lopez's research into the latest prostate cancer treatments, clinical trials, experimental therapies — anything to avoid chemotherapy, and a recommendation from a friend also battling prostate cancer, led him to Tanya Dorff, M.D., and City of Hope.
Metabolic disease: Who's at risk? What can be done? (w/PODCAST)
September 28, 2015 | City of Hope
Metabolism is the chemical processes that occur within a living organism in order to maintain life. But what causes disorders of the metabolism, including diabetes?
Women's cancers: Support is vital in, and after, cancer treatment
March 16, 2014 | Elizabeth Stewart
In this series – this part focuses on the need for support during, and after, treatment – we explore crucial strides made against women's cancers by City of Hope researchers during the past year. The projects are many and varied, involving the basics of fighting cancer, analyses of who's at greatest risk, the search for surprising new therapies, the testing of new treatments, and the follow-up with survivors and their partners.
Orange rind could aid search for anti-cancer, anti-obesity drug
July 26, 2013 | Nicole White
Not only is a single protein now believed to be implicated in three of the most serious health threats today – cancer, diabetes and obesity – scientists are currently charting the course toward clinical trials targeting the protein.